Contract 75A50119C00075
Emergent Biosolutions Canada Inc · Department Of Health And Human Services · September 30, 2019
Emergent Biosolutions Canada Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 30, 2019 for $256.40 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 14 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 30, 2026.
Contract details
- PIID
- 75A50119C00075
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 30, 2019
- Latest action
- March 30, 2026
Description
EO14042 BOTULISM ANTITOXIN
Modification timeline
-
March 30, 2026Mod P00014$0
-
June 11, 2025Mod P00013$62.39M
-
June 2, 2025Mod P00012$0
-
March 4, 2025Mod P00011$0
-
June 10, 2024Mod P00010$60.28M
-
February 23, 2024Mod P00009$0
-
May 19, 2023Mod P00008$72.24M
-
March 23, 2023Mod P00007$0
-
August 2, 2022Mod P00006$11.50M
-
October 22, 2021Mod P00005$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
| Bavarian Nordic, Inc. | Department Of Health And Human Services | March 27, 2026 | $127.5K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50119C00075?
Contract 75A50119C00075 is a federal contract awarded to Emergent Biosolutions Canada Inc by Department Of Health And Human Services on September 30, 2019 for $256.40 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 14 times since the base award.
Who won contract 75A50119C00075?
Emergent Biosolutions Canada Inc won contract 75A50119C00075 from Department Of Health And Human Services.
How much is contract 75A50119C00075 worth?
Contract 75A50119C00075 has obligated $256.40 million to date.